Abstract
Asthma is a pathophysiological condition associated with eosinophilia and heightened inflammatory reactions, epithelial desquamation, hyper responsiveness, recurring episodes of reversible broncho-constriction, and mucus hyper secretion from the respiratory organs. Asthma interludes can be triggered by a variety of factors most notably allergens, infectious agents, pollutants, and nonspecific stimuli such as exercise, nutritional factors and emotional stress. Certain genes and their polymorphism may also have effects in the initiation and progression of asthma. Thus asthma may also be classified as atopic (extrinsic) or non-atopic (intrinsic). Here atopy refers to a predisposition towards developing type 1 hypersensitivity reactions. In a present day scenario asthma is termed as a complex genetic disorder with a heterogeneous phenotype, largely attributed to the interactions between genes and/or environment. Hence, pharmacogenomics is an important area to understand the influence of genetic variations on drug response in asthmatics by correlating gene expression or single-nucleotide polymorphisms (SNPs) with drug's efficacy. This article reviews the role of various genes and their polymorphism in initiation, complication of asthma and its treatment strategies focussing on disease causing polymorphic and novel genes.
Keywords: Asthma, eosinophilia, genetic polymorphism, novel genes, pharmacogenomics.
Current Respiratory Medicine Reviews
Title:Recent Advances in Asthma Genetics and Antiasthma Therapy
Volume: 9 Issue: 4
Author(s): Daizee Talukdar, Narender Chaudhry, Rohit Sharma, Raman Kumar and Tapan K. Mukherjee
Affiliation:
Keywords: Asthma, eosinophilia, genetic polymorphism, novel genes, pharmacogenomics.
Abstract: Asthma is a pathophysiological condition associated with eosinophilia and heightened inflammatory reactions, epithelial desquamation, hyper responsiveness, recurring episodes of reversible broncho-constriction, and mucus hyper secretion from the respiratory organs. Asthma interludes can be triggered by a variety of factors most notably allergens, infectious agents, pollutants, and nonspecific stimuli such as exercise, nutritional factors and emotional stress. Certain genes and their polymorphism may also have effects in the initiation and progression of asthma. Thus asthma may also be classified as atopic (extrinsic) or non-atopic (intrinsic). Here atopy refers to a predisposition towards developing type 1 hypersensitivity reactions. In a present day scenario asthma is termed as a complex genetic disorder with a heterogeneous phenotype, largely attributed to the interactions between genes and/or environment. Hence, pharmacogenomics is an important area to understand the influence of genetic variations on drug response in asthmatics by correlating gene expression or single-nucleotide polymorphisms (SNPs) with drug's efficacy. This article reviews the role of various genes and their polymorphism in initiation, complication of asthma and its treatment strategies focussing on disease causing polymorphic and novel genes.
Export Options
About this article
Cite this article as:
Talukdar Daizee, Chaudhry Narender, Sharma Rohit, Kumar Raman and Mukherjee K. Tapan, Recent Advances in Asthma Genetics and Antiasthma Therapy, Current Respiratory Medicine Reviews 2013; 9 (4) . https://dx.doi.org/10.2174/1573398X09666131217002352
DOI https://dx.doi.org/10.2174/1573398X09666131217002352 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biomarkers of Lung Tissue Remodeling in Pulmonary Diseases: Implications for Clinical Practice and Research
Current Respiratory Medicine Reviews Omega – 3 Fatty Acids as Pharmacotherapeutics in Psoriasis: Current Status and Scope of Nanomedicine in its Effective Delivery
Current Drug Targets Statins as Anti-Inflammatory Agents in Atherogenesis: Molecular Mechanisms and Lessons from the Recent Clinical Trials
Current Pharmaceutical Design Immune Defence Mechanisms: Comparing Upper and Lower Airways in Chronic Airway Diseases
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Activated Immune System and Inflammation in Healthy Ageing: Relevance for Tryptophan and Neopterin Metabolism
Current Pharmaceutical Design Chronic Diseases and COVID-19: A Review
Endocrine, Metabolic & Immune Disorders - Drug Targets Allergenic Tropomyosins and Their Cross-Reactivities
Protein & Peptide Letters A Novel Nanoformulation of Ellagic Acid is Promising in Restoring Oxidative Homeostasis in Rat Brains with Alzheimer’s Disease
Current Drug Metabolism Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Nanocarriers in Improved Heparin Delivery: Recent Updates
Current Pharmaceutical Design Systems Biology Approaches to Pancreatic Cancer Detection, Prevention and Treatment
Current Pharmaceutical Design Methods to Measure Target Site Penetration of Antibiotics in Critically Ill Patients
Current Clinical Pharmacology Targeting Aberrant TGF-β Signaling in Pre-Clinical Models of Cancer
Anti-Cancer Agents in Medicinal Chemistry Peripheral TRPV1 Receptors As Targets for Drug Development: New Molecules and Mechanisms
Current Pharmaceutical Design Editorial
Recent Patents on Inflammation & Allergy Drug Discovery Patenting on Non Oral Anti-Allergic Drug
Recent Patents on Inflammation & Allergy Drug Discovery New Approved Medications for Idiopathic Pulmonary Fibrosis
Current Drug Therapy New Developments on Thromboxane and Prostacyclin Modulators Part I: Thromboxane Modulators
Current Medicinal Chemistry The Physiology of Nitric Oxide: Control and Consequences
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Second Messenger Modulation: A Novel Target of Future Antidepressants?
Current Medicinal Chemistry